Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 5,188 | 2,863 | 3,020 | 2,367 | 2,985 |
| Operating Income | -5,188 | -2,863 | -3,020 | -2,367 | -2,985 |
| Interest Expense | 22 | 22 | 21 | 22 | 80 |
| Other Income | 73 | 101 | 43 | 14 | 15 |
| Pre-tax Income | -5,137 | -2,784 | -2,998 | -2,375 | -3,050 |
| Net Income Continuous | -5,137 | -2,784 | -2,998 | -2,375 | -3,050 |
| Net Income | $-5,137 | $-2,784 | $-2,998 | $-2,375 | $-3,050 |
| EPS Basic Total Ops | -0.08 | -0.05 | -0.06 | -0.20 | -0.08 |
| EPS Basic Continuous Ops | -0.09 | -0.05 | -0.06 | -0.05 | -0.07 |
| EPS Diluted Total Ops | -0.08 | -0.05 | -0.06 | -0.20 | -0.08 |
| EPS Diluted Continuous Ops | -0.09 | -0.05 | -0.06 | -0.05 | -0.07 |
| EBITDA(a) | $-5,179 | $-2,855 | $-3,012 | $-2,357 | $-2,985 |